BZBiao Zhao

Biao Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Biao Zhao has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    TMEM187 is a novel modulator in the regulation of erythropoiesis

    by Yutong Liu, Wenxin Zhang, Jing Cai, Di Zhou, Hongting Zhao, Weichen Dong, Biao Zhao, Yao Lu, Shuangying Hao, Yibing Ding, et al.

    Erythropoiesis, the process of red blood cell production, is highly dependent on iron uptake via transferrin and its receptor, transferrin receptor 1 (TfR1), but the mechanisms governing the proper recycling of TfR1 in relation to cellular iron demands remain elusive. Here, we identify human TMEM187, a Golgi transmembrane protein of unknown function, as a novel negative regulator of erythropoiesis. Lack of TMEM187 in a cell model initiates erythropoiesis without the normal induction protocol and accelerates iron uptake. Following the induction protocol, TMEM187 ablation leads to premature erythroid maturation, resulting in early phosphatidylserine ectopia and cell membrane fragility, hallmarks of cellular senescence that renders the cells susceptible to macrophage recognition and phagocytosis. In zebrafish embryos, tmem187 deletion leads to enhanced early erythropoiesis, although the phenotype is later compensated, whereas hematopoietic stem-cell expression of human TMEM187 in mice, which lack endogenously a homologous gene, resulted in compromised erythropoiesis and moderate anemia. Mechanistically, we demonstrate that TMEM187 interacts with RAB11 to restrain endosomal recycling, interfering with RAB11-GRAB association that activates RAB11. Consequently, TMEM187 modulates TfR1 recycling to the cell membrane to fine-tune iron uptake efficiency for erythropoiesis. Our findings reveal a novel modulatory pathway in which TMEM187 plays a crucial role in regulating erythroid differentiation, maturation, and senescence, providing a previously unexplored perspective of TMEM187's physiological function.


  • Open Access

    Low Wall Shear Stress Promotes Atheroma via Arterial Iron Accumulation

    by Lei Zheng, Zhenxi Zhang, Yutong Liu, Chen Cheng, Biao Zhao, Run Ji, Zhipeng Chen, Liu Yang, Jing Cai, Kuanyu Li, et al.

    BACKGROUND: Low wall shear stress (WSS) at arterial bifurcations and curves damages endothelial cells, promoting the development of atherosclerosis. Although the accumulation of iron in plaques has been observed, the mechanisms behind it and its effects are not fully understood. METHODS: Detect the iron content in different parts of the mouse partial carotid artery ligation model and the aorta. The chelating iron therapy was used to assess the impact of low WSS–induced iron accumulation and atherosclerosis in the arterial wall. In vitro experiments utilized human umbilical vein endothelial cells and an orbital-shaker model to simulate WSS. Mice with endothelial cell–specific knockout of IRP2 (iron regulatory protein 2) and deletion of Apoe (Apolipoprotein e; Apoe −/− IRP2 iEcko ) were constructed, as well as a human umbilical vein endothelial cell line with IRP2 knockdown. RESULTS: We investigated the iron accumulation induced by low WSS in carotid arteries. Hinokitiol, an iron chelator, was found to reduce this iron buildup and decrease the progression of atherosclerosis. Low WSS in the carotid arteries led to chronic iron accumulation, which altered the expression of iron metabolism–related proteins in endothelial cells, particularly IRP2. Knocking down IRP2 in endothelial cells resulted in an increase in the expression of inflammation-related proteins and a significant elevation in the expression of HIFs (hypoxia-inducible factors). Apoe −/− IRP2 iEcko mice exhibited an increased susceptibility to atherosclerosis. The use of HIF inhibitors, PX-478 and PT-2385, was able to suppress the exacerbation of atherosclerosis in Apoe −/− mice caused by the endothelial cell–specific knockout of IRP2 . CONCLUSIONS: Our results indicate that low WSS–induced endothelial cell iron metabolism abnormalities, by inducing arterial wall iron accumulation and abnormal expression of iron metabolism–related proteins, promote the occurrence and development of atherosclerosis. The use of iron chelators can alleviate the onset and progression of low WSS–induced atherosclerosis.